Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Therapy: Vitamin B6, B9 and B12 in diabetic nephropathy--beware.

Literature DB >> 20720587

Therapy: Vitamin B6, B9 and B12 in diabetic nephropathy--beware.

Paul J Thornalley, Naila Rabbani.

Abstract

Entities: Chemical Disease

Mesh：

Substances：

Year: 2010 PMID： 20720587 DOI： 10.1038/nrendo.2010.124

Source DB: PubMed Journal: Nat Rev Endocrinol ISSN： 1759-5029 Impact factor: 43.330

× No keyword cloud information.

10 in total

1. Effects of pyridoxamine in combined phase 2 studies of patients with type 1 and type 2 diabetes and overt nephropathy.

Authors: Mark E Williams; W Kline Bolton; Raja G Khalifah; Thorsten P Degenhardt; Robert J Schotzinger; Janet B McGill
Journal: Am J Nephrol Date: 2007-09-06 Impact factor: 3.754

2. Randomized controlled trial of the effect of short-term coadministration of methylcobalamin and folate on serum ADMA concentration in patients receiving long-term hemodialysis.

Authors: Katsushi Koyama; Akinori Ito; Jun Yamamoto; Takae Nishio; Junko Kajikuri; Yasuaki Dohi; Nobuyuki Ohte; Akira Sano; Hiroshi Nakamura; Hiromichi Kumagai; Takeo Itoh
Journal: Am J Kidney Dis Date: 2010-04-28 Impact factor: 8.860

3. Effect of B-vitamin therapy on progression of diabetic nephropathy: a randomized controlled trial.

Authors: Andrew A House; Misha Eliasziw; Daniel C Cattran; David N Churchill; Matthew J Oliver; Adrian Fine; George K Dresser; J David Spence
Journal: JAMA Date: 2010-04-28 Impact factor: 56.272

4. Reduced folate carrier transports thiamine monophosphate: an alternative route for thiamine delivery into mammalian cells.

Authors: Rongbao Zhao; Feng Gao; I David Goldman
Journal: Am J Physiol Cell Physiol Date: 2002-06 Impact factor: 4.249

5. Homocysteine lowering with folic acid and B vitamins in vascular disease.

Authors: Eva Lonn; Salim Yusuf; Malcolm J Arnold; Patrick Sheridan; Janice Pogue; Mary Micks; Matthew J McQueen; Jeffrey Probstfield; George Fodor; Claes Held; Jacques Genest
Journal: N Engl J Med Date: 2006-03-12 Impact factor: 91.245

6. High-dose thiamine therapy for patients with type 2 diabetes and microalbuminuria: a randomised, double-blind placebo-controlled pilot study.

Authors: N Rabbani; S S Alam; S Riaz; J R Larkin; M W Akhtar; T Shafi; P J Thornalley
Journal: Diabetologia Date: 2008-12-05 Impact factor: 10.122

7. Plasma concentration of asymmetric dimethylarginine (ADMA) predicts cardiovascular morbidity and mortality in type 1 diabetic patients with diabetic nephropathy.

Authors: Maria Lajer; Lise Tarnow; Anders Jorsal; Tom Teerlink; Hans-Henrik Parving; Peter Rossing
Journal: Diabetes Care Date: 2007-12-27 Impact factor: 19.112

8. Cancer incidence and mortality after treatment with folic acid and vitamin B12.

Authors: Marta Ebbing; Kaare Harald Bønaa; Ottar Nygård; Egil Arnesen; Per Magne Ueland; Jan Erik Nordrehaug; Knut Rasmussen; Inger Njølstad; Helga Refsum; Dennis W Nilsen; Aage Tverdal; Klaus Meyer; Stein Emil Vollset
Journal: JAMA Date: 2009-11-18 Impact factor: 56.272

Review 9. The potential role of thiamine (vitamin B1) in diabetic complications.

Authors: Paul J Thornalley
Journal: Curr Diabetes Rev Date: 2005-08

10. Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized controlled trial.

Authors: Rex L Jamison; Pamela Hartigan; James S Kaufman; David S Goldfarb; Stuart R Warren; Peter D Guarino; J Michael Gaziano
Journal: JAMA Date: 2007-09-12 Impact factor: 56.272

10 in total

6 in total

1. Amadori glycated proteins: role in production of autoantibodies in diabetes mellitus and effect of inhibitors on non-enzymatic glycation.

Authors: Nadeem A Ansari; Debabrata Dash
Journal: Aging Dis Date: 2012-12-10 Impact factor: 6.745